Chinese mobile health app, Xingren Doctor, announced Wednesday that it has raised 200 million RMB (roughly $32 million USD) in series B financing led by FountainVest Partners, followed by current investors Sequoia Capital China and LightSpeed China Partners.
The investment will go primarily into product development and improving their overall business model, said Martin Shen, founder and CEO of the company.
Xingren Doctor is an mobile healthcare app targeted at doctors, helping them to better manage patients, workplace communications and industry updates. Available for both iOS and Android, doctors in China are using this app to communicate and track the status of their patients, contact other doctors on the network, or follow trends within their specialties.
Start your free trial now.
Get instant access to all our premium content, archives, newsletters, and online community.
Monthly Membership
Yearly Membership
What you get
Full access to all premium content and our full archives
Members'-only newsletters
Preferential access and discounts to all TechNode events
Direct access to the TechNode newsroom
Start your free trial now.
Get instant access to all our premium content, archives, newsletters, and online community.